Elanco Animal Health INC Form 4 insider transactions

David S. Kinard, an executive at Elanco Animal Health Inc., was granted stock options with a vesting schedule spanning three years.

Director Kapila K. Anand has elected to defer her director cash retainer fees into Elanco Animal Health Inc. stock units.

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving deferred stock units.

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving deferred stock units.

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving deferred stock units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 116.9603 deferred stock units on June 12, 2026, valued at $24.17 per unit.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, reported a transaction involving deferred stock units on June 12, 2026.

Elanco Animal Health EVP and CFO, Robert M. VanHimbergen, reported a transaction involving deferred stock units on May 29, 2026.

Rajeev A. Modi of Elanco Animal Health reports a transaction involving deferred stock units, settling 61,9258 units on May 29, 2026.

Jeffrey N. Simmons, CEO of Elanco Animal Health, reported a transaction involving deferred stock units on May 29, 2026.

Denise Scots-Knight, a Director at Elanco Animal Health Inc., reported the acquisition of deferred stock units and restricted stock units on May 21, 2026.

Lawrence Kurzius, a Director at Elanco Animal Health Inc., received deferred stock units and restricted stock units on May 21, 2026, as part of annual equity awards.

Kirk P. McDonald, a Director at Elanco Animal Health Inc., received deferred stock units and restricted stock units as part of annual equity awards.

Elanco Animal Health Inc. reports on equity awards granted to its non-employee directors, including deferred stock units and restricted stock units.

Deborah Turner Kochevar, a Director at Elanco Animal Health Inc., was granted deferred stock units as part of an annual equity award.

R. David Hoover, a Director at Elanco Animal Health Inc., received a grant of deferred stock units as part of an annual equity award.

Michael J. Harrington, a Director at Elanco Animal Health Inc., received deferred stock units and restricted stock units as part of annual equity awards.

Elanco Animal Health Inc. reports that Director Anand Kapila acquired shares through grants of deferred and restricted stock units.

Stacey Ma, a Director at Elanco Animal Health Inc., has reported the acquisition of deferred stock units and restricted stock units.

Director Art A. Garcia of Elanco Animal Health Inc. acquired shares through equity awards, increasing his beneficial ownership.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired company shares and deferred stock units on May 15, 2026.

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving the acquisition of common stock.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, reported a transaction involving deferred stock units.

Elanco Animal Health Inc. reports a transaction involving deferred stock units by President, CEO, and Director Jeffrey N. Simmons.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 119.3805 deferred stock units as part of the company's executive compensation plan.

Elanco Animal Health CFO Robert M. VanHimbergen acquired 8.3201 deferred stock units as part of a company compensation plan.

Elanco Animal Health executive Rajeev A. Modi acquired 62.3704 deferred stock units as part of a company compensation plan.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired deferred stock units representing the right to receive company common stock.

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving deferred stock units.

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., acquired deferred stock units representing the right to receive company common stock.